Veryan Medical
Developing 3-D vascular stents for the treatment of peripheral vascular disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
Veryan Medical specializes in developing advanced vascular stent technology that mimics the natural 3D helical shape of the human vascular system. This biomimetic approach aims to improve the performance and efficacy of vascular stents, which are medical devices used to keep blood vessels open. The company's flagship product, the BioMimics 3D stent, represents a new generation of self-expanding stents designed to more closely replicate the natural geometry of blood vessels, thereby enhancing blood flow and reducing complications.
Veryan Medical primarily serves healthcare providers and medical institutions that require cutting-edge vascular solutions. Operating in the medical device market, the company focuses on innovation and research to stay ahead in a competitive landscape.
The business model revolves around the development, regulatory approval, and commercialization of its proprietary stent technology. Revenue is generated through the sale of these stents to hospitals and clinics, often facilitated by partnerships with medical distributors and direct sales teams.
Keywords: vascular stents, biomimicry, 3D helical shape, BioMimics 3D, medical devices, healthcare, innovation, blood flow, self-expanding stents, vascular solutions.